Page last updated: 2024-08-21

vancomycin and ppi-0903

vancomycin has been researched along with ppi-0903 in 86 studies

Research

Studies (86)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (8.14)	29.6817
2010's	60 (69.77)	24.3611
2020's	19 (22.09)	2.80

Authors

Authors	Studies
Bugnon, D; Caillon, J; Ge, JY; Hamel, A; Jacqueline, C; Le Mabecque, V; Miègeville, AF; Potel, G	1
Fritsche, TR; Jones, RN; Sader, HS	1
Biek, D; Ge, Y; Sahm, DF; Talbot, GH	1
Fisher, JF; Llarrull, LI; Mobashery, S	1
Batard, E; Biek, D; Caillon, J; Ge, Y; Jacqueline, C; Le Mabecque, V; Miègeville, AF; Potel, G	1
Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR	1
Johnson, L; Pawlak, J; Saravolatz, L	1
Das, A; Ge, Y; Talbot, GH; Thye, D	1
Leonard, SN; Rybak, MJ; Vidaillac, C	2
Amador, G; Batard, E; Biek, D; Caillon, J; Ge, Y; Hamel, A; Jacqueline, C; Le Mabecque, V; Miègeville, AF; Potel, G	1
Baculik, T; Corey, GR; Critchley, I; Das, AF; Friedland, HD; Talbot, GH; Thye, D; Wilcox, M; Witherell, GW	1
Baculik, T; Corey, GR; Friedland, D; Talbot, GH; Thye, D; Wilcox, MH	2
Corrado, ML	1
Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS	1
Drusano, GL	1
Biek, D; Eckburg, PB; Friedland, HD; Laudano, JB; Llorens, L; O'Neal, T; Rank, DR; Smith, A; Thye, D; Witherell, GW	1
Ahn, SH; Biek, D; Critchley, I; Fowler, VG; Lamlertthon, S; Llorens, L; Rude, T; Ruffin, F; Sharma-Kuinkel, BK; Tamarana, G; Tong, A; Tong, SY; Zhang, Y	1
Graviss, EA; Marconescu, P; Musher, DM	1
Pogliano, J; Rose, WE; Rybak, MJ; Sakoulas, G; Tewhey, R; Werth, BJ	1
Giuliano, C; Johnson, LB; Kale-Pradhan, PB	1
Das, D; Garcia, LG; Lemaire, S; Mélard, A; Rozenberg, R; Tulkens, PM; Van Bambeke, F	1
Heidari, A; Jongsma, K; Joson, J	1
Murray, KP; Newton, KL; Nonejuie, P; Pogliano, J; Rybak, MJ; Sakoulas, G; Vidaillac, C; Werth, BJ	1
Kaatz, GW; Rybak, MJ; Steed, ME; Werth, BJ	1
Flamm, RK; Jones, RN; Sader, HS	1
Beresford, E; Friedland, HD; Huang, X; Lodise, T	1
Dalhoff, A; Schubert, S	1
Bhalodi, AA; Hagihara, M; Kuti, JL; Nicolau, DP	1
Crispell, EK; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; McDanel, JS; Riahi, F; Richter, SS; Satola, SW	1
Muscedere, J	1
Johnson, LB; Martin, H; Pawlak, J; Saravolatz, LD; Saravolatz, SN	1
Barber, KE; Ireland, CE; Rybak, MJ; Werth, BJ	1
Barber, KE; Rybak, MJ; Sakoulas, G	1
Crémieux, AC; Gatin, L; Ghout, I; Laurent, F; Saleh-Mghir, A; Tasse, J	1
Adelman, MH; Bader, J; Crane, JK; Jacobs, DM; Paladino, JA; Schentag, JJ; Shields, RK; Taylor, J; Wilton, GJ	1
Kuti, JL; MacVane, SH; Nicolau, DP; So, W	1
Stahlmann, R	1
Espedido, BA; Jensen, SO; van Hal, SJ	1
Eckmann, C	1
Barber, KE; Raut, A; Rybak, MJ; Smith, JR	1
Mahfood Haddad, T; Sundaragiri, PR; Vallabhajosyula, S; Vivekanandan, R	1
Gomes, DM; LaPlante, KL; Ward, KE	1
Barber, KE; Boles, BR; Ireland, CE; Rose, WE; Rybak, MJ; Smith, JR	1
Baos, E; Candel, FJ; Nieto, M; Picazo, JJ	1
Esterbrooks, DJ; Haddad, TM; Sundaragiri, PR; Vallabhajosyula, S	1
Raut, A; Rybak, MJ; Smith, JR; Yim, J	1
Blumer, JL; Bradley, JS; Cannavino, C; Friedland, HD; Ghonghadze, T; Jandourek, A; O'Neal, T	1
Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F	1
Deresinski, S; Holubar, M; Meng, L	1
Fang, H; Fröding, I; Gian, B; Hæggman, S; Nord, CE; Tollström, UB; Ullberg, M	1
Athans, V; Davis, SL; Kenney, RM; Wong, J	1
Candel, FJ; Chiarella, F; García, AB; López, L; Viñuela-Prieto, JM	1
Dryden, M; Gonzalez, J; Iaconis, JP; Wilson, D; Zhang, Y	1
Casapao, AM; Claeys, KC; Davis, SL; Klinker, KP; Lagnf, AM; Rybak, MJ; Sabagha, N; Trinh, TD; Zasowski, EJ	1
Altshuler, J; Fedorenko, M; Gritsenko, D; Ruhe, JJ	1
Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R	1
Domínguez-Herrera, J; Labrador-Herrera, G; López-Rojas, R; Pachón, J; Smani, Y	1
Arshad, S; Hartman, P; Huang, V; Moreno, D; Perri, MB; Zervos, MJ	1
Arias, CA; Carvajal, LP; Chambers, HF; Diaz, L; Garavito, JD; Miller, WR; Munita, JM; Nigo, M; Panesso, D; Rios, R; Tran, TT; Wanger, A; Weinstock, G	1
Bloom, A; DeYoung, H; Tamayo, S	1
Chan, D; Chang, E; Saedi-Kwon, H; Schwartz, J; Turner, RB; Wilson, DE; Won, R	1
Rybak, MJ; Tran, N	1
Cuénod, A; Egli, A; Hinic, V; Khanna, N; Kuehl, R; Morgenstern, M; Wüthrich, D	1
Jamal, M; Nesher, L; Prince, RA; Raad, I; Rice, SA; Rolston, KVI; Rybak, MJ	1
Gil Romero, Y; Gómez-Garcés, JL	1
Claeys, KC; Davis, SL; Delaportes, DJ; Estrada, SJ; Huang, V; Jorgensen, SCJ; Kaye, KS; Klinker, KP; Lagnf, AM; Rybak, MJ; Trinh, TD; Zasowski, EJ	1
Awad, AR; Elawady, BA; ElFeky, DS; Elshobaky, MA	1
Karahan, ZC; Ozmen Capin, BB; Tekeli, A	1
Epps, KL; Epps, QJ; Young, DC; Zobell, JT	1
Cuba, GT; da Costa, TM; Dos Santos, KRN; Kiffer, CRV; Morgado, PGM; Nicolau, DP; Nouér, SA	1
Arda, B; Aydemir, S; Bolat, E; Mermer, S; Pullukcu, H; Sipahi, H; Sipahi, OR; Turhan, T; Ulusoy, S; Yamazhan, T	1
Benner, K; Branstetter, J; Crowder, C; Searcy, H; Troxler, B; Yarbrough, A	1
Herc, ES; Hutton, MA; Perri, MB; Sundaram, A; Zervos, MJ	1
Alegria, W; Deresinski, S; Holubar, M; Meng, L	1
Algorri, M; Wong-Beringer, A	1
Cowart, MC; Ferguson, CL; Jordan-Villegas, A; Laham, F	1
Huang, M; Johnson, TM; Kiser, TH; Miller, MA; Molina, KC; Mueller, SW	1
Dahdouh, E; Díaz-Pollán, B; Falces-Romero, I; Gómez-Gil, R; Mingorance, J	1
Esquivel, MD; Finklea, JD; Monogue, ML; Sanders, JM; Smith, GS	1
Abate, G; Frisby, J; Wang, G	1
Chang, SC; Chen, YC; Chuang, YC; Sheng, WH; Tsai, CE; Wang, JT; Yang, CJ	1
Blaine, BE; Kufel, WD; Mahapatra, R; Paolino, KM; Parsels, KA; Steele, JM; Thomas, SJ	1
Pawlak, J; Saravolatz, LD	1
Butin, M; Callies, A; Crémet, L; Flamant, C; Gély, L; Gregoire, M; Guillouzouic, A; Launay, E; Martin-Perceval, L; Prot-Labarthe, S; Ruellan, AL; Verdier, MC	1

Reviews

9 review(s) available for vancomycin and ppi-0903

Article	Year
Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactams; Cell Wall; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Penicillin-Binding Proteins; Peptide Synthases; Staphylococcus aureus	2009
[Antibiotics for treatment of infections by methicillin-resistant Staphylococcus aureus (MRSA)]. Pneumologie (Stuttgart, Germany), 2014, Volume: 68, Issue:10 Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Evidence-Based Medicine; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin	2014
Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus. Pharmacotherapy, 2015, Volume: 35, Issue:4 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Linezolid; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2015
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs. Internal and emergency medicine, 2016, Volume: 11, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin	2016
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches. Infectious disease clinics of North America, 2016, Volume: 30, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin	2016
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA. BMC infectious diseases, 2017, 01-07, Volume: 17, Issue:1 Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin	2017
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics. Pediatric pulmonology, 2020, Volume: 55, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin	2020
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches. Infectious disease clinics of North America, 2020, Volume: 34, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin	2020
Ceftaroline: Systematic Review of Clinical Uses and Emerging Drug Resistance. The Annals of pharmacotherapy, 2022, Volume: 56, Issue:12 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Daptomycin; Drug Resistance; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin	2022

Trials

8 trial(s) available for vancomycin and ppi-0903

Article	Year
Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10 Topics: Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Female; Humans; Male; Methicillin Resistance; Middle Aged; Recurrence; Skin Diseases, Infectious; Streptococcus agalactiae; Treatment Outcome; Vancomycin	2007
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Sep-15, Volume: 51, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin; Young Adult	2010
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. The Journal of antimicrobial chemotherapy, 2010, Volume: 65 Suppl 4 Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult	2010
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. The Journal of antimicrobial chemotherapy, 2010, Volume: 65 Suppl 4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult	2010
Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. The Journal of antimicrobial chemotherapy, 2010, Volume: 65 Suppl 4 Topics: Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin	2010
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Biomarkers; Ceftaroline; Cephalosporins; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin	2012
A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia. The Pediatric infectious disease journal, 2016, Volume: 35, Issue:7 Topics: Adolescent; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Female; Humans; Infant; Infusions, Intravenous; Male; Pneumonia, Bacterial; Treatment Outcome; Vancomycin	2016
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:12 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vancomycin; Young Adult	2016

Other Studies

69 other study(ies) available for vancomycin and ppi-0903

Article	Year
In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9 Topics: Acetamides; Animals; Anti-Bacterial Agents; Area Under Curve; Ceftaroline; Cephalosporins; Chromatography, High Pressure Liquid; Colony Count, Microbial; Endocarditis, Bacterial; Immunoenzyme Techniques; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance	2007
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States	2008
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States	2008
In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and van Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Acetamides; Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Endocarditis, Bacterial; Enterococcus faecalis; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Vancomycin; Vancomycin Resistance	2009
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States	2010
In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, and daptomycin-nonsusceptible Staphylococcus aureus isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin; Vancomycin Resistance	2010
In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate S. aureus in a hollow fiber model. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:11 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Biological; Staphylococcus aureus; Vancomycin	2009
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates. International journal of antimicrobial agents, 2010, Volume: 35, Issue:6 Topics: Acetamides; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Tobramycin; Vancomycin	2010
Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:8 Topics: Acetamides; Animals; Anti-Bacterial Agents; Bone and Bones; Bone Marrow; Ceftaroline; Cephalosporins; Disease Models, Animal; Female; Linezolid; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Oxazolidinones; Rabbits; Staphylococcal Infections; Treatment Outcome; Vancomycin	2010
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9 Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin	2011
Early endpoints for acute bacterial skin and skin structure infections. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Aztreonam; Biomarkers; Ceftaroline; Cephalosporins; Female; Humans; Male; Skin Diseases, Bacterial; Vancomycin	2012
Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies. PloS one, 2012, Volume: 7, Issue:5 Topics: Age Factors; Aztreonam; Bacterial Toxins; Ceftaroline; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Exotoxins; Female; Genotype; Humans; Leukocidins; Male; Methicillin-Resistant Staphylococcus aureus; Polymerase Chain Reaction; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin	2012
Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin. Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:8 Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Daptomycin; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin	2012
Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1 Topics: Aminoacyltransferases; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Ceftaroline; Cell Membrane; Cell Wall; Cephalosporins; Colony Count, Microbial; Daptomycin; Drug Combinations; Drug Synergism; Fluorescent Dyes; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Models, Biological; Mutation; Vancomycin; Vancomycin Resistance	2013
Early response of ceftaroline fosamic in the treatment of soft-tissue infections. Expert review of clinical pharmacology, 2012, Volume: 5, Issue:5 Topics: Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Community-Acquired Infections; Endpoint Determination; Humans; Pneumonia; Randomized Controlled Trials as Topic; Retrospective Studies; Soft Tissue Infections; Time Factors; Treatment Outcome; Vancomycin	2012
Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monocytes; Oxazolidinones; Vancomycin	2013
Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:6 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Debridement; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin	2013
Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5 Topics: Anti-Bacterial Agents; Boron Compounds; Ceftaroline; Cell Wall; Cephalosporins; Drug Combinations; Drug Synergism; Fluorescent Dyes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Vancomycin Resistance	2013
Evaluation of ceftaroline activity against heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate methicillin-resistant S. aureus strains in an in vitro pharmacokinetic/pharmacodynamic model: exploring the "seesaw effect Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcus aureus; Vancomycin; Vancomycin Resistance	2013
Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2013
Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Jun-15, Volume: 70, Issue:12 Topics: Acute Disease; Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Costs and Cost Analysis; Drug Therapy, Combination; Economics, Hospital; Formularies, Hospital as Topic; Humans; Length of Stay; Models, Economic; Skin Diseases, Bacterial; Vancomycin	2013
Evaluation of the effect of serum proteins on the antibacterial activity and pharmacodynamics of ceftaroline against Staphylococcus aureus. International journal of antimicrobial agents, 2013, Volume: 42, Issue:3 Topics: Anti-Bacterial Agents; Blood Proteins; Ceftaroline; Ceftriaxone; Cephalosporins; Microbial Sensitivity Tests; Protein Binding; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2013
In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Daptomycin; Drug Combinations; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Statistical; Vancomycin; Vancomycin Resistance	2014
Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; United States; Vancomycin; Vancomycin Resistance	2014
Which antibiotic for hospital acquired pneumonia caused by MRSA? BMJ (Clinical research ed.), 2014, Feb-13, Volume: 348 Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin	2014
Ceftaroline-heteroresistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance	2014
Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Computer Simulation; Daptomycin; Drug Combinations; Endocarditis, Bacterial; Half-Life; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin	2014
Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Treatment Outcome; Vancomycin	2015
Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Disease Models, Animal; Drug Resistance, Bacterial; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Vancomycin	2014
Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations. International journal of antimicrobial agents, 2014, Volume: 44, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ceftaroline; Cephalosporins; Demography; Disease Eradication; Female; Glycopeptides; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Time Factors; Treatment Failure; Vancomycin	2014
In vitro activity of human-simulated epithelial lining fluid exposures of ceftaroline, ceftriaxone, and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12 Topics: Anti-Bacterial Agents; Area Under Curve; Biomimetic Materials; Ceftaroline; Ceftriaxone; Cephalosporins; Colony Count, Microbial; Extracellular Fluid; Humans; Methicillin-Resistant Staphylococcus aureus; Models, Statistical; Respiratory Mucosa; Vancomycin	2014
Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:3 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Drug Tolerance; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Salvage Therapy; Staphylococcal Infections; Vancomycin	2015
[Efficacy of ceftaroline in treating complicated skin and soft tissue infections]. Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139 Suppl 3 Topics: Aztreonam; Ceftaroline; Cephalosporins; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin	2014
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:5 Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Ertapenem; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci	2015
Mycotic pseudoaneurysm by vancomycin-intermediate Staphylococcus aureus: a rare cause of persistent bacteraemia. BMJ case reports, 2015, Apr-01, Volume: 2015 Topics: Aneurysm, False; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Debridement; Diagnosis, Differential; Drug Resistance, Microbial; Femoral Artery; Humans; Ligation; Male; Middle Aged; Mycoses; Staphylococcus aureus; Thigh; Vancomycin; Venous Thrombosis	2015
Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Anti-Bacterial Agents; Biofilms; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Half-Life; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Vancomycin	2015
Could ceftaroline be an alternative therapy for linezolid resistant Staphylococcus epidermidis infections in Intensive Care Medicine? Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2015, Volume: 28, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; Body Fluids; Catheter-Related Infections; Ceftaroline; Cephalosporins; Critical Care; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Humans; Linezolid; Methicillin; Minocycline; Staphylococcal Infections; Staphylococcus epidermidis; Tigecycline; Vancomycin	2015
Tricuspid and mitral endocarditis due to methicillin-resistant Staphylococcus aureus exhibiting vancomycin-creep phenomenon. BMJ case reports, 2015, Nov-03, Volume: 2015 Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Fatal Outcome; Heart Valve Diseases; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Staphylococcal Infections; Tricuspid Valve; Vancomycin	2015
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci	2016
Methicillin-resistant Staphylococcus aureus in Stockholm, Sweden: Molecular epidemiology and antimicrobial susceptibilities to ceftaroline, linezolid, mupirocin and vancomycin in 2014. Journal of global antimicrobial resistance, 2016, Volume: 5 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ceftaroline; Cephalosporins; Genotype; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Mupirocin; Staphylococcal Infections; Sweden; Vancomycin	2016
Outpatient use of ceftaroline fosamil versus vancomycin for osteoarticular infection: a matched cohort study. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:12 Topics: Adult; Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Osteoarthritis; Outpatients; Patient Readmission; Retrospective Studies; Treatment Outcome; Vancomycin	2016
In vitro ceftaroline combinations against meticillin-resistant Staphylococcus aureus. Journal of medical microbiology, 2016, Volume: 65, Issue:10 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin	2016
Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:2 Topics: Aged; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Endocarditis; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin	2017
Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series. Clinical therapeutics, 2017, Volume: 39, Issue:1 Topics: Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Salvage Therapy; Staphylococcal Infections; Vancomycin	2017
Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis. International journal of antimicrobial agents, 2016, Volume: 48, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Ceftaroline; Cephalosporins; Disease Models, Animal; Female; Foreign Bodies; Methicillin Resistance; Mice, Inbred C57BL; Microbial Sensitivity Tests; Random Allocation; Sepsis; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin	2016
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 57 Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Female; Hospitalization; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Michigan; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Salvage Therapy; Staphylococcal Infections; Treatment Outcome; Vancomycin	2017
Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3 Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gene Expression; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections; Vancomycin	2017
Successful treatment of community-acquired methicillin-resistant Staphylococcus aureus purulent myopericarditis. BMJ case reports, 2017, Oct-10, Volume: 2017 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Myocarditis; Pericardial Effusion; Pericardiectomy; Pericarditis; Postoperative Complications; Staphylococcal Infections; Steroids; Treatment Outcome; Vancomycin	2017
Comparative analysis of neutropenia in patients receiving prolonged treatment with ceftaroline. The Journal of antimicrobial chemotherapy, 2018, 03-01, Volume: 73, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Female; Humans; Incidence; Leukocyte Count; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutropenia; Retrospective Studies; Staphylococcal Infections; Vancomycin	2018
β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:6 Topics: beta-Lactams; Cefazolin; Cefepime; Ceftaroline; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin	2018
Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline. The Journal of antimicrobial chemotherapy, 2019, 05-01, Volume: 74, Issue:5 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Genomics; Humans; Inpatients; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymorphism, Single Nucleotide; Staphylococcal Infections; Vancomycin	2019
Bactericidal activity of ceftaroline, vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolates from cancer patients. Journal of global antimicrobial resistance, 2019, Volume: 17 Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neoplasms; Staphylococcal Infections; Vancomycin	2019
In vitro activity of ceftaroline in combination with other antimicrobials active against Staphylococcus spp. Enfermedades infecciosas y microbiologia clinica (English ed.), 2020, Volume: 38, Issue:1 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Synergism; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin	2020
Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:11 Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Female; Humans; Male; Middle Aged; Retrospective Studies; Skin; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin	2019
Effect of Ceftaroline, Vancomycin, Gentamicin, Macrolides, and Ciprofloxacin against Methicillin-Resistant Surgical infections, 2020, Volume: 21, Issue:2 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gentamicins; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin	2020
Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Microbial drug resistance (Larchmont, N.Y.), 2020, Volume: 26, Issue:3 Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Genes, Bacterial; Humans; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phylogeny; Rifampin; Staphylococcal Infections; Tetracycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin	2020
Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration. BMC infectious diseases, 2020, Jan-23, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; Brazil; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monte Carlo Method; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2020
Ceftaroline versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in an experimental MRSA meningitis model. Journal of global antimicrobial resistance, 2020, Volume: 22 Topics: Animals; Ceftaroline; Cephalosporins; Meningitis; Methicillin-Resistant Staphylococcus aureus; Rabbits; Staphylococcal Infections; Vancomycin	2020
Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis. Pediatric pulmonology, 2020, Volume: 55, Issue:12 Topics: Administration, Intravenous; Adolescent; Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin; Young Adult	2020
Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus. Diagnostic microbiology and infectious disease, 2020, Volume: 98, Issue:3 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2020
Differential effects of antibiotics on neutrophils exposed to lipoteichoic acid derived from Staphylococcus aureus. Annals of clinical microbiology and antimicrobials, 2020, Nov-03, Volume: 19, Issue:1 Topics: Anti-Bacterial Agents; CD11b Antigen; Ceftaroline; Cephalosporins; Daptomycin; Humans; L-Selectin; Lipopolysaccharides; Neutrophils; Phagocytosis; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Vancomycin	2020
High-level ceftaroline resistance in a paediatric patient with invasive methicillin-resistant Staphylococcus aureus infection without previous ceftaroline exposure. Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:2 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Female; Humans; Infant; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin	2021
Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care. International journal of antimicrobial agents, 2021, Volume: 57, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Salvage Therapy; Standard of Care; Staphylococcal Infections; Treatment Outcome; Vancomycin	2021
Characterization of an osteomyelitis case caused by dalbavancin, ceftaroline, and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:9 Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Teicoplanin; Vancomycin; Whole Genome Sequencing	2021
Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults. Journal of global antimicrobial resistance, 2022, Volume: 28 Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cohort Studies; Cystic Fibrosis; Humans; Lung; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin	2022
Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 122 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin	2022
Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia. Pharmacotherapy, 2023, Volume: 43, Issue:1 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin	2023
In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid. The Journal of antimicrobial chemotherapy, 2022, 12-23, Volume: 78, Issue:1 Topics: Anti-Bacterial Agents; Cefazolin; Ceftaroline; Daptomycin; Fosfomycin; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2022
Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series Analysis. The Pediatric infectious disease journal, 2023, 10-01, Volume: 42, Issue:10 Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Humans; Infant; Infant, Newborn; Neonatal Sepsis; Sepsis; Staphylococcal Infections; Vancomycin	2023